Univariable analysis showed that tumor size, lymph node metastasis, tumor grade, ER status, PgR status, chemotherapy administration, CEA levels, and CA15-3 levels were significant prognostic factors for DFS (Table 3). This evidence concerns the gene ESR1 and metastatic malignant neoplasm in the lymph nodes.